Tekmira Provides Periodic Update to Shareholders Regarding Litigation – GlobeNewsWire (press release)
VANCOUVER, British Columbia, May 24, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today provided a periodic update to its shareholders on the ...
Subscribe to LegalLaw247.Com Newsletter